GeneDx Holdings (WGS) Gains from Investment Securities (2020 - 2026)

GeneDx Holdings (WGS) has 7 years of Gains from Investment Securities data on file, last reported at $495000.0 in Q1 2026.

• Gains from Investment Securities for Q1 2026 came in at $495000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $2.9 million (up 31.64% YoY), and the FY2025 annual result was $2.5 million, down 9.22% from the prior year.
• Gains from Investment Securities improved to $495000.0 in Q1 2026 per WGS's latest filing, from $131000.0 in the prior quarter.
• Over five years, Gains from Investment Securities peaked at $57.6 million in Q4 2022 and troughed at -$56.0 million in Q3 2022.
• A 5-year average of $485500.0 and a median of $511500.0 in 2024 frame the typical range for Gains from Investment Securities.
• The sharpest annual moves came in 2024 and 2025: Gains from Investment Securities soared 1041.6% in 2024, then tumbled 304.73% in 2025.
• A 5-year view of Gains from Investment Securities shows it stood at $57.6 million in 2022, then sank by 105.73% to -$3.3 million in 2023, then plunged by 163.09% to -$8.7 million in 2024, then jumped by 101.51% to $131000.0 in 2025, then soared by 277.86% to $495000.0 in 2026.
• Business Quant data shows WGS's Gains from Investment Securities at $495000.0 in Q1 2026, $131000.0 in Q4 2025, and $3.4 million in Q3 2025.